Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors

Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors

US Patent 11685745 · Granted Jun 27, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bolter miner and tunneling system2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof2024
Substituted furanopyrimidine compounds as PDE1 inhibitors2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonis2023